In-Person Access Only | Earn 8.5 CME Credits & MOC Points

Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

The Third Annual Hematology Think Tank: Now and Tomorrow will take place April 29–May 1, 2027, in Chicago, Illinois. This highly interactive educational forum brings together internationally recognized leaders in malignant hematology to examine the current state of care while exploring the innovations that will define the future of the field. Through expert presentations, multidisciplinary panel discussions, audience engagement, and select debates, faculty will address emerging data, evolving treatment paradigms, translational research, cellular therapies, precision medicine, and the practical challenges of integrating new evidence into clinical practice. Covering a broad spectrum of hematologic malignancies— including leukemias, lymphomas, myeloma, myelodysplastic syndromes, myeloproliferative neoplasms, and CAR T-cell therapy—the program is designed to foster meaningful collaboration and provide actionable insights that attendees can immediately apply to patient care. This program will be hosted as an in-person event only.

Conference Agenda
Thursday, April 29, 2027 - Saturday, May 1, 2027

Program Chairs:
Chadi Nabhan, MD, MBA, FACP

Thursday, April 29, 2027

6:30 PM
VIP Faculty & Staff Dinner

Friday, May 1, 2027

7:15 AM
Registration Opens

7:30 AM
Breakfast and Exhibits

8:00 AM
Non-CME Breakfast

8:45 AM
Coffee Break

9:00 AM
Opening Remarks

9:15 AM
MDS Think Tank

9:45 AM
MPS Think Tank

10:15 AM
CAR-T Think Tank

10:45 AM
Coffee and Snack Break

11:00 AM
CLL Think Tank

11:30 AM
Hodgkin Lymphoma Think Tank

12:00 PM
Lunch and Exhibits

12:30 PM
Non-CME Lunch

1:15 PM
Networking, Housekeeping Notes and Survey

1:45 PM
ALL Think Tank

2:15 PM
AML Think Tank

2:45 PM
CML Think Tank

3:15 PM
Coffee and Snack Break

3:30 PM
Debate 1: CLL, Time-Limited vs. Continuous BTKI Therapy

4:00 PM
Q&A

4:20 PM
The Healthcare Unfiltered Think Tank Annual Award Lecture (Sponsorship Opportunity)

4:50 PM
Break & Transition

5:05 PM
Simultaneous Focus Groups, as applicable

6:05 PM
ADJOURN

6:30 PM
Inclusive Networking Reception for All Invited Attendees

Saturday, May 1, 2027

7:15 AM
Registration Opens

7:30 AM
Breakfast and Exhibits

8:00 AM
Non-CME Breakfast

8:45 AM
Coffee Break

9:00 AM
Opening Remarks and Day 2 Overview

9:15 AM
T-Cell Lymphoma Think Tank

9:45 AM
DLBCL Think Tank

10:15 AM
Follicular Lymphoma Think Tank

10:45 AM
Coffee and Snack Break

11:00 AM
Multiple Myeloma Think Tank

11:30 AM
Debate 2: ctDNA Guides Therapy in Lymphoma
Yes
No

12:15 PM
Lunch and Exhibits

12:45 PM
Non-CME Lunch

1:30 PM
Housekeeping and Survey

2:00 PM
Concluding Remarks/Transition

2:15 PM
Simultaneous Focus Groups, as applicable

3:30 PM
ADJOURN

• Learning Objectives

  • Review recent clinical advances in the treatment of cancers, with a focus on the most relevant data from recent studies and clinical trials.

  • Evaluate the role of emerging therapies in cancer treatment, including new medications, targeted therapies, and immunotherapies.

  • Apply evidence-based strategies to improve patient outcomes in community oncology settings, focusing on the integration of new treatment approaches.

  • Assess and manage side effects and toxicities associated with current and emerging therapies in cancer patients.

  • Discuss multidisciplinary care approaches that enhance collaboration between oncologists, pharmacists, nurses, and advanced practitioners in treating cancers.

• Accreditation Information | 8.5 Credits

• What to Expect | In-Person Learners

  • Complimentary registration for healthcare professionals

  • Expert-led Think Tank discussions featuring internationally recognized hematology leaders

  • Interactive multidisciplinary panels exploring today's challenges and tomorrow's innovations

  • Practical clinical insights spanning malignant hematology, cellular therapies, and precision medicine

  • Thought-provoking debates on emerging areas of clinical controversy

  • Opportunities to engage directly with faculty through audience discussion and Q&A

  • Networking with leading clinicians, researchers, and industry partners

  • The latest advances in hematology research, novel therapeutics, biomarker-driven care, and clinical trial data